Metabolic Manipulation of Glioblastoma in Vivo by Retrograde Microdialysis of L-2, 4 Diaminobutyric Acid (DAB)
- 14 June 2006
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 80 (3), 285-293
- https://doi.org/10.1007/s11060-006-9186-1
Abstract
To study the metabolic effects in vivo of L-2, 4 diaminobutyric acid (DAB) administered by retrograde microdialysis in glioblastoma and to evaluate the feasibility of the technique. In 10 patients with glioblastoma, a stereotactic biopsy was performed followed by implantation of microdialysis catheters. One or two catheters were implanted in tumor tissue and two reference catheters were implanted in normal brain tissue and subcutaneous abdominal tissue, respectively. Tumor catheters were perfused with 80 or 120 mmol/l DAB and reference catheters were perfused with a Ringer solution, all with a flow rate of 2.0 µl/min. Treatment was given for at mean 9.1 (5–19) days. The treatment was well tolerated by the patients with the exception of two patients in whom a transient brain edema appeared. No complications related to the technique were encountered. During treatment, an increase in the extracellular amino acids alanine, glycine, glutamate, aspartate, serine, threonine, and taurine was found demonstrating a significant influence on the intracellular pool of free amino acids induced by DAB. No change in glucose metabolism or glycerol was evident. The metabolism in normal brain was unaffected during treatment. Retrograde microdialysis is a feasible method for intracerebral administration of drugs to tumor tissue in patients with glioblastoma. We found it possible to deliver DAB to glioblastoma tumors in fully mobilized patients and to assess the metabolic effects induced by the treatment. The changes in extracellular amino acids were in concordance to what was expected from in vitro studies. Elevation of glutamate and taurine may be regarded as markers for an induced cellular toxicity while the unchanged level of glycerol may indicate no direct effects on phospholipase activity and membrane phospholipid composition. The effects were restricted to the tumor compartment. Although an improved survival could possibly be suspected no dramatic effect on outcome could be detected. However, the series was small and, most probably, the time for treatment was too short.Keywords
This publication has 37 references indexed in Scilit:
- Potentiation of the Osmosensitive Release of Taurine and d-Aspartate from SH-SY5Y Neuroblastoma Cells after Activation of M3Muscarinic Cholinergic ReceptorsThe Journal of pharmacology and experimental therapeutics, 2004
- Volume changes and whole cell membrane currents activated during gradual osmolarity decrease in C6 glioma cells: contribution of two types of K+ channelsAmerican Journal of Physiology-Cell Physiology, 2004
- Release of the excitotoxic amino acids, glutamate and aspartate, from the isolated ischemic/anoxic rat heartNeuroscience Letters, 1996
- The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trialJournal of Neuro-Oncology, 1995
- Value of Surgical Intervention in the Treatment of GliomaStereotactic and Functional Neurosurgery, 1995
- A comparative study on ventriculographic and computerized tomography-guided determinations of brain targets in functional stereotaxisJournal of Neurosurgery, 1990
- Microdialysis in the human brain: Extracellular measurements in the thalamus of parkinsonian patientsLife Sciences, 1990
- An adapter for computed tomography-guided stereotaxisSurgical Neurology, 1985
- α-Aminoisobutyric Acid Transport into Human Glia and Glioma Cells in CultureJournal of Cellular Physiology, 1976
- Energization of amino acid transport, studied for the Ehrlich ascites tumor cellBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1973